Tinzaparin versus enoxaparin after total hip replacement.22
| . | Thrombosis . | |||
|---|---|---|---|---|
| Drug . | Proximal . | Distal . | Total*# . | Major Bleding . |
| *Risk Difference = 1.6% (95% CI = - 6.0% - 9.2%); interpreted as showing equivalence. | ||||
| # Only 5 of 92 (5.4%) were clinically manifest. | ||||
| enoxaparin (n = 219) | 23 | 21 | 44 | 4 |
| tinzaparin (n = 221) | 21 | 27 | 48 | 2 |
| . | Thrombosis . | |||
|---|---|---|---|---|
| Drug . | Proximal . | Distal . | Total*# . | Major Bleding . |
| *Risk Difference = 1.6% (95% CI = - 6.0% - 9.2%); interpreted as showing equivalence. | ||||
| # Only 5 of 92 (5.4%) were clinically manifest. | ||||
| enoxaparin (n = 219) | 23 | 21 | 44 | 4 |
| tinzaparin (n = 221) | 21 | 27 | 48 | 2 |